ACR-2316

· Acrivon Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACR-2316, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors [Phase 1]